Short answer
TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on July 7, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation). Additional $1.9 million revolving-credit draw received June 30, 2026 for general corporate purposes.
TuHURA Biosciences, Inc./NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.03 · Creation of a Direct Financial Obligation
- Additional $1.9 million revolving-credit draw received June 30, 2026 for general corporate purposes
- Facility maximum availability $50 million, providing further liquidity capacity
- Maturity April 21, 2031, extending financing runway but increasing future repayment obligations
- Parkview Holdings One LLC serves as lender under the existing Loan Agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TuHURA Biosciences, Inc./NV 8-K filings
Get the next HURA 8-K as it lands
Follow HURA for push alerts, or ask the research agent what this filing means.